Functional Assessment of Lesions: Advances with MRI

Computer tomography (CT) had taken over in the race to develop software capable of measuring FFR non-invasively. Magnetic resonance imaging (MRI) wouldn’t fall behind and has also tried non-inferiority vs an FFR based strategy, according to this study recently published in the prestigious NEJM, called MR-INFORM.

In patients with chronic angina and CAD risk factors, MR perfusion was associated to lower revascularization incidence, and also resulted non-inferior compared to FFR as regards major cardiac events.

All evidence (and guidelines alongside) points to ischemia driven revascularization. Anatomy lags making room to function, when it comes to deciding for or against revascularization. Obviously, once the decision has been made, tools such as IVUS or OCT are extremely useful for strategy planning. In fact, IVUS in particular has shown to reduce mortality when guiding PCI, and this is especially true for left main lesions.

The MR-INFORM randomized 918 patients with typical angina and at least two cardiovascular risk factors or a positive stress test to MR based strategy vs. FFR based strategy.


Read also: TCT 2018 | ULTIMATE: IVUS Guided DES Implantation for All Vessels, for All Lesions.


Revascularization was recommended for patients with at least 6% ischemia in MRI or in 0.8 or lower FFR.

Primary end point was a composite of death, non-fatal infarction or target vessel revascularization at one year. Non-inferiority cutoff value was a risk difference of 6%.

A total 184 over 454 (40.5%) in the MRI group and 213 of 464 in the FFR group (45.9%) met the criteria to recommend revascularization (p=0.11), though the MRI group saw fewer revascularizations (35.7% vs 45%; p=0.005).


Read also: The use of IVUS in unprotected left main PCI associated to better outcomes, compared to angiography guided PCI.


Primary end point occurred in 3.6% of patients in the MRI group vs. 3.7% in the FFR guided group; with these figures the MRI based strategy reached non-inferiority.

At one year, the percentage of patients free from angina resulted similar between the groups (49.2% in the MRI group vs 43.8% in the FFR).

Conclusion

In patients with chronic stable angina and CAE risk factors, myocardial perfusion cardiovascular MRI was associated with lower revascularization rate compared against the FFR based strategy and, in addition, MRI resulted non-inferior in major cardiovascular events.

Original Title: Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.

Reference: Eike Nagel et al. N Engl J Med 2019;380:2418-28.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...